Home6938 • HKG
add
Suzhou Ribo Life Science Co Ltd
Previous close
$74.05
Year range
$58.55 - $95.80
Market cap
12.63B HKD
Avg Volume
1.05M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 51.91M | 56.57% |
Operating expense | 91.45M | 4.66% |
Net income | -44.06M | 35.93% |
Net profit margin | -84.88 | 59.08% |
Earnings per share | — | — |
EBITDA | -35.87M | 24.30% |
Effective tax rate | -4.15% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 549.27M | — |
Total assets | 1.00B | — |
Total liabilities | 941.56M | — |
Total equity | 59.02M | — |
Shares outstanding | 130.15M | — |
Price to book | -164.56 | — |
Return on assets | -11.35% | — |
Return on capital | -20.22% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -44.06M | 35.93% |
Cash from operations | -48.24M | -305.15% |
Cash from investing | -92.16M | -1,637.52% |
Cash from financing | 235.87M | 2,145.70% |
Net change in cash | 95.33M | 236.15% |
Free cash flow | -15.65M | — |
About
Founded
Jan 18, 2007
Website
Employees
404
